BCL2L1 and colonic neoplasm: Butyrate also inhibits STAT3 signaling, thus suppressing the expression of bcl-2, bcl-XL, c-myc, cyclin D1, and HIF-1, resulting in decreased cell proliferation and increased apoptosis in both hypoxia and in colon cancer [31].